The Current Ratio as of December 2025 (TTM) for DuoGenic StemCells corporation (7607.TWO) is 1.08

According to DuoGenic StemCells corporation’s latest financial reports and current stock price. The company's current Current Ratio is 1.08. This represents a change of -64.54% compared to the average of 3.06 of the last 4 quarters.

DuoGenic StemCells corporation (7607.TWO) Historical Current Ratio (quarterly & annually)

How has 7607.TWO Current Ratio performed in the past?

The mean historical Current Ratio of DuoGenic StemCells corporation over the last ten years is 7.60. The current 1.08 Current Ratio has changed 1.33% with respect to the historical average. Over the past ten years (40 quarters), 7607.TWO's Current Ratio was at its highest in in the June 2022 quarter at 20.02. The Current Ratio was at its lowest in in the December 2024 quarter at 0.96.

DuoGenic StemCells corporation (7607.TWO) Current Ratio by Quarter and Year

Discovering the peaks and valleys of DuoGenic StemCells corporation Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

DuoGenic StemCells corporation (7607.TWO) Average Current Ratio

How has 7607.TWO Current Ratio performed in the past?

The current Current Ratio of DuoGenic StemCells corporation (7607.TWO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

DuoGenic StemCells corporation (7607.TWO) Current Ratio vs. Peers

How is 7607.TWO’s Current Ratio compared to its peers?

DuoGenic StemCells corporation’s Current Ratio is less than EPS Bio Technology Corp. (2.19), less than Taiwan Advanced Nanotech Inc. (3.69), less than UniPharma Co., Ltd. (6.19), less than Pharmigene, Inc. (2.46), less than Sunder Biomedical Tech. Co., Ltd. (1.33), less than Welgene Biotech Co.,Ltd. (2.51), less than A-SPINE Asia Co., Ltd. (1.68), less than Health & Life Co., Ltd. (3.27), greater than iXensor Co., Ltd. (0.53), less than Vectorite Biomedical Inc. (13.46),

Build a custom stock screener for DuoGenic StemCells corporation (7607.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like DuoGenic StemCells corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

DuoGenic StemCells corporation (7607.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like DuoGenic StemCells corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.